sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
31-Oct-2014 05:13
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 226-250 out of 912.

<< < 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 > >>

Public Release: 13-Jun-2014
Journal of Christian Nursing
Nurses play critical role in responding to global resurgence of pertussis
Pertussis (whooping cough) is on the increase in the United States and around the world --and nurses play an essential role in educating parents and patients about the safety and effectiveness of pertussis vaccination, according to a paper in the July-September issue of Journal of Christian Nursing, official journal of the Nurses Christian Fellowship. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

Contact: Connie Hughes
Connie.Hughes@wolterskluwer.com
646-674-6348
Wolters Kluwer Health

Public Release: 13-Jun-2014
Nature Communications
Genetic 'barcode' for malaria could help contain outbreaks
A new genetic 'barcode' for malaria parasites has been found which could be used to track and contain the spread of the disease, according to new research led by the London School of Hygiene & Tropical Medicine. By using this simple genetic marker when analyzing blood samples from malaria patients, organizations could quickly and accurately identify the source of outbreaks, and spot the spread of drug-resistant parasites from Asia to Africa.

Contact: Joel Winston
press@lshtm.ac.uk
44-020-792-72802
London School of Hygiene & Tropical Medicine

Public Release: 12-Jun-2014
Grant to entomologist will advance research on African malaria mosquito
Bradley White, an entomologist at the University of California, Riverside, has received a five-year grant exceeding $1.8 million from the National Institute of Allergy and Infectious Diseases. The grant will allow his lab to produce fine-scale recombination rate maps for the African malaria mosquito, Anopheles gambiae. At 31, White is one of the youngest NIH R01 principal investigators in the country (well less than 1 percent of NIH principal investigators are 31 or younger).
NIH/National Institute of Allergy and Infectious Diseases

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside

Public Release: 10-Jun-2014
Proceedings of the National Academy of Sciences
LSTM researchers identify the complex mechanisms controlling changes in snake venom
Specialist researchers from LSTM have identified the diverse mechanisms by which variations in venom occur in related snake species and the significant differences in venom pathology that occur as a consequence.

Contact: Clare Bebb
c.bebb@liv.ac.uk
44-015-170-53135
Liverpool School of Tropical Medicine

Public Release: 10-Jun-2014
Nature Communications
Scientists wipe out malaria-carrying mosquitoes in the lab by creating male-only offspring
Scientists have modified mosquitoes to produce sperm that will only create males, pioneering a fresh approach to eradicating malaria.
National Institutes of Health

Contact: Gail Wilson
gail.wilson@imperial.ac.uk
44-020-759-46702
Imperial College London

Public Release: 10-Jun-2014
Journal of Applied Physics
Malaria: Blood cells behaving badly
New insight into how malaria parasites perturb flow, turning infected cells into sticky capillary cloggers, may lead to new and better treatments.

Contact: Jason Bardi
jbardi@aip.org
240-535-4954
American Institute of Physics

Public Release: 10-Jun-2014
PLOS Medicine
Refugees and internally displaced persons should have equitable access to HIV treatment
'Given recent evidence and the moral, legal, and public health arguments, refugees and internally displaced persons situated in stable settings should have equitable access to HIV treatment and supportive services,' argue experts from the London School of Hygiene & Tropical Medicine and the United Nations High Commissioner for Refugees, writing in this week's PLOS Medicine.
United Nations High Commissioner for Refugees

Contact: Maya Sandler
medicinepress@plos.org
PLOS

Public Release: 6-Jun-2014
Nature Communications
Toward a better drug against malaria
A research team led by Prof. Dr. Carola Hunte of the University of Freiburg, Germany, has succeeded in describing how the antimalarial drug atovaquone binds to its target protein. The scientists used x-ray crystallography to determine the three-dimensional structure of the protein with the active substance bound. The drug combination atovaquone-proguanil (Malarone®) is a medication used worldwide for the prevention and treatment of malaria.

Contact: Dr. Carola Hunte
carola.hunte@biochemie.uni-freiburg.de
49-761-203-5279
University of Freiburg

Public Release: 6-Jun-2014
PLOS Neglected Tropical Diseases
Deadly diseases overlooked for too long, scientists say
Decades of neglect have allowed infectious diseases to devastate the lives of thousands of people in the developing world, a study reveals.
European Commission

Contact: Corin Campbell
Corin.Campbell@ed.ac.uk
01-316-502-246
University of Edinburgh

Public Release: 6-Jun-2014
Nature Communications
Infection in malaria-transmitting mosquito discovered
Researchers have found the first evidence of an intercellular bacterial infection in natural populations of two species of Anopheles mosquitoes, the major vectors of malaria in Africa.
European Research Council

Contact: Todd Datz
tdatz@hsph.harvard.edu
617-432-8413
Harvard School of Public Health

Public Release: 5-Jun-2014
UH chemist's work could impact disease management, treatments
A University of Houston chemist hopes his work will one day impact the treatment of such diseases as cancer and malaria by better understanding how molecules react and how atoms come together to form bonds. Jeremy May, an assistant professor of chemistry at UH, received a five-year, $600,000 National Science Foundation CAREER Award to develop synthetic strategies to increase the efficiency and yields of chemical reactions.
National Science Foundation

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston

Public Release: 4-Jun-2014
Proceedings of the National Academy of Sciences
Hemorrhagic fevers can be caused by body's antiviral interferon response
Virologists and immunologists at The Scripps Research Institute have found a major clue to the mystery of 'hemorrhagic fever' syndromes. The team showed that Interferon Type I immune proteins are key drivers of a viral syndrome in mice that closely mimics human hemorrhagic fevers.
National Institutes of Health

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute

Public Release: 4-Jun-2014
Shared mission of health equity joins NYU GIPH and HealthRight International
A unique collaboration between New York University's Global Institute of Public Health (NYU GIPH) and the global health and human rights organization HealthRight International, Inc. was announced today by Robert Berne, New York University executive vice president for health, Dr. Cheryl Healton, dean of Global Public Health and director of NYU GIPH, and Dr. Peter Navario, HealthRight executive director. NYU GIPH and HealthRight will collaborate on global health programming, research, curricula, work-study placements, and internships.

Contact: Robert Polner
robert.polner@nyu.edu
212-998-2337
New York University

Public Release: 3-Jun-2014
Global health grant from the Bill & Melinda Gates Foundation awarded to the University of Surrey
The University of Surrey announced today that it has been awarded a Grand Challenges Explorations grant, an initiative funded by the Bill & Melinda Gates Foundation. With the grant, Professor Johnjoe McFadden will aim to revolutionize the control of tuberculosis by modifying the vaccine and designing a new test for the human form of the disease.
Bill & Melinda Gates Foundation

Contact: Peter La
p.la@surrey.ac.uk
01-483-689-191
University of Surrey

Public Release: 3-Jun-2014
Hepatology
Liver cancer vaccine effective in mice
Tweaking a protein expressed by most liver cancer cells has enabled scientists to make a vaccine that is exceedingly effective at preventing the disease in mice.
NIH/National Cancer Institute

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 30-May-2014
UTHealth's Anil Kulkarni awarded Fulbright Scholarship
Anil Kulkarni, MSc, Ph.D., professor in the Department of Surgery at The University of Texas Health Science Center at Houston Medical School, was awarded a highly competitive Fulbright-Nehru Scholarship Award for Academic and Professional Experience to travel to India this fall to teach immunonutrition and functional foods in the global health era.
Fulbright-Nehru Scholarship Award for Academic and Professional Experience

Contact: Robert Cahill
Robert.Cahill@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston

Public Release: 28-May-2014
Sexually Transmitted Infections
In Africa, STI testing could boost HIV prevention
Sexually transmitted infections can make HIV transmission more likely, undermining the prevention benefit of HIV treatment. A new study of HIV-positive patients in Cape Town, South Africa, found that the prevalence of such co-infections was much higher before beginning HIV treatment. Testing for and treating STIs and HIV together could therefore improve HIV prevention.
National Institutes of Health

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 28-May-2014
Journal of Tropical Medicine
Experimental trial represents promising step toward universal antidote for snakebite
A team of researchers, led by Dr. Matthew Lewin of the California Academy of Sciences and Dr. Stephen P. Samuel of Trinity College Dublin, Ireland has taken another promising step toward developing a universal antidote for snakebite. The results of this pilot study were recently published in the Journal of Tropical Medicine. These findings support the team's idea that providing fast, accessible, and easy-to-administer treatment can increase survival rates in victims of venomous snakebite.

Contact: Kelly Mendez
kmendez@calacademy.org
415-379-5133
California Academy of Sciences

Public Release: 28-May-2014
Lancet
Nearly one-third of the world's population is obese or overweight, new data show
Today, 2.1 billion people -- nearly 30 percent of the world's population -- are either obese or overweight, according to a new, first-of-its kind analysis of trend data from 188 countries. The rise in global obesity rates over the last three decades has been substantial and widespread, presenting a major public health epidemic in both the developed and the developing world.

Contact: Rhonda Stewart
stewartr@uw.edu
206-897-2863
Institute for Health Metrics and Evaluation

Public Release: 27-May-2014
PLOS Medicine
Barriers to HIV testing in older children
Concerns about guardianship and privacy can discourage clinics from testing children for HIV, according to new research from Zimbabwe published this week in PLOS Medicine. The results of the study, by Rashida A. Ferrand of the London School of Hygiene & Tropical Medicine and colleagues, provide much-needed information on how to improve care of this vulnerable population.
Wellcome Trust

Contact: Maya Sandler
medicinepress@plos.org
PLOS

Public Release: 23-May-2014
Rising star uses paper to tackle food-borne diseases
UAlberta post-doc's idea for paper-based diagnostic tool earns place among Grand Challenges Canada's Stars in Global Health.
Grand Challenges Canada

Contact: Bryan Alary
bryan.alary@ualberta.ca
780-492-0436
University of Alberta

Public Release: 22-May-2014
Science
Scientists identify potential vaccine candidate for pediatric malaria
Researchers have identified a substance, or antigen, that generates antibodies that can hinder the ability of malaria parasites to multiply, which may protect against severe malaria infection. The antigen, known as PfSEA-1, was associated with reduced parasite levels among children and adults in malaria-endemic areas.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jennifer Routh
jennifer.routh@nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 22-May-2014
The Royal Society: Antimicrobial resistance -- addressing the threat to global health
Nature
Antibiotic crisis needs united global response, experts say
Growing resistance to antibiotics and other drugs demands a coordinated global response on the same scale as efforts to address climate change, say experts from the University of Edinburgh and the Wellcome Trust.

Contact: Jen Middleton
jen.middleton@ed.ac.uk
44-131-650-6514
University of Edinburgh

Public Release: 22-May-2014
Science
RI Hospital researcher and colleagues discover protein that may lead to malaria vaccine
Rhode Island Hospital researchers have discovered a protein that is essential for malaria-causing parasites to escape from inside red blood cells. This protein could lead to the development of a vaccine that would prevent the progression of Plasmodium falciparum malaria, which kills one child every 15 seconds each year in Sub-Saharan Africa and Southeast Asia, according to new research by Jonathan Kurtis, M.D., Ph.D., and colleagues.
National Institutes of Health, Bill and Melinda Gates Foundation

Contact: Ellen Slingsby
eslingsby@lifespan.org
401-444-6421
Lifespan

Public Release: 21-May-2014
Trends in Parasitology
Scientist uncovers links connecting environmental changes with spike in infectious disease
Smithsonian scientist Bert Van Bocxlaer and a team of researchers revealed that anthropogenic changes in Africa's Lake Malaŵi are a driving force behind the increase of urogenital schistosomiasis, a debilitating disease caused by parasitic flatworms. In some villages along Lake Malaŵi, 73 percent of people and up to 94 percent of schoolchildren are infected. The research suggests the spike in infection is linked to an increase in human populations and agricultural activities near Lake Malaŵi.

Contact: Kathryn Sabella
sabellak@si.edu
202-633-2950
Smithsonian

Showing releases 226-250 out of 912.

<< < 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 > >>